4.6 Article

Incremental and Personalized Hemodialysis Start: A New Standard of Care

Journal

KIDNEY INTERNATIONAL REPORTS
Volume 7, Issue 7, Pages 1049-1061

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ekir.2022.02.010

Keywords

incremental hemodialysis; personalized hemodialysis; predialysis care; propensity score matching; survival

Ask authors/readers for more resources

The aim of this study was to evaluate the effects of incremental hemodialysis (iHD) as the standard of care at the start of hemodialysis on mortality, morbidity, and costs. The results showed that iHD is safe and feasible, and can be considered as a new standard of care in incident hemodialysis patients.
Introduction: Incremental hemodialysis (iHD) may attenuate dialysis shock and reduce costs, preserving quality of life. It is considered difficult to reconcile with HD wards' routine; fear of underdialysis and increasing mortality are additional concerns. The aim of this study was to evaluate mortality, morbidity, and costs in a large HD ward where iHD is the standard of HD start. Methods: This observational study included all incident HD patients in 2017 to 2021, stratified according to HD start: iHD (1-2 sessions/wk), decremental HD (dHD, 3 sessions/wk at start, later reduced), or standard (3 sessions/wk). Results were compared with data recorded in the same unit before the incremental program (2015-2017) and with a propensity score-matched cohort from the French Renal Epidemiology and Information Network (REIN) registry. Results: A total of 158 patients started HD in 2017 to 2021, 57.6% on iHD, 8.9% dHD, and 33.5% standard HD schedule. Patients on the standard schedule had lower initial estimated glomerular filtration rate (eGFR) (5 vs. 7 ml/min per 1.72m(2), P = 0.003). We found no survival differences according to period of start (same center) and propensity score matching (REIN). Patients intensively followed in the pre-HD period were more likely to start on iHD-dHD. Persistence on iHD-dHD was about 50% at 1 year and 35% at 2 years. Hospitalization rates and time to first hospitalization or death did not differ between the schedules. The iHD-dHD policy allowed a 16% cost saving, even accounting for supplemental biochemical tests. Conclusion: Our study reveals that iHD can be a new standard of care, as it is safe and feasible in up to twothirds of patients on incident HD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available